Co-culture of retinal and endothelial cells results in the modulation of genes critical to retinal neovascularization

Vascular Cell

Volumn 3, Issue , 2011, Pages

  Kumar, Ravindra ^a   Harris Hooker, Sandra ^a   Kumar, Ritesh ^b   Sanford, Gary ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Co culture; Conditioned medium; Human retinal progenitor cells (HRPC); Human umbilical vein endothelial cells (HUVEC); Hypoxia; Neovascularization; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL COMMUNICATION; CELL NUCLEUS; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GENE CONTROL; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HYPOXIA; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA CELL; RETINA NEOVASCULARIZATION; STEM CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84863418965     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-3-27     Document Type: Article

References (46)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease. Folkman J, Nature Med 1995 1 27 31 10.1038/nm0195-27 7584949
2. Angiogenesis in cancer and other diseases. Carmeliet P, Jain RK, Nature 2000 407 249 257 10.1038/35025220 11001068
3. Vascular endothelial growth factor in eye disease. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME, Prog Retin Eye Res 2008 27 331 71 10.1016/j.preteyeres.2008.05.001 18653375
4. Angiogenesis. Folkman J, Annu Rev Med 2006 57 1 18 10.1146/annurev.med. 57.121304.131306 16409133 (Pubitemid 43261975)
5. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT, Am J Ophthalmol 1994 118 445 450 7943121 (Pubitemid 24307211)
6. Ocular neovascularization: a valuable model system. Campochiaro PA, Hackett SF, Oncogene 2003 22 6537 6548 10.1038/sj.onc.1206773 14528278 (Pubitemid 37372333)
7. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE, Proc Natl Acad Sci USA 1995 92 905 9 10.1073/pnas.92.3.905 7846076
8. Retinal vascular endothelial cell growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy. Donahue ML, Phelps DL, Watkins RH, LoMonaco MB, Horowitz S, Curr Eye Res 1996 15 175 84 10.3109/02713689608997411 8670726 (Pubitemid 26089050)
9. Vascular endothelial growth factors and angiogenesis in eye disease. Witmer AN, Vrensen GF, Prog Retin Eye Res 2003 22 1 29 10.1016/S1350-9462(02) 00043-5 12597922 (Pubitemid 36207453)
10. Regulation of angiogenesis by hypoxia: Role of the HIF system. Pugh CW, Ratcliffe PJ, Nat Med 2003 9 677 684 10.1038/nm0603-677 12778166 (Pubitemid 36749216)
11. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Bracken CP, Whitelaw ML, Peet DJ, Cell Mol Life Sci 2003 60 1376 1396 10.1007/s00018-003-2370-y 12943226 (Pubitemid 36900521)
12. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. Kim B-S, Chen J, Weinstein T, Noiri E, Goligorsky MS, J Am Soc Nephrol 2002 13 2027 36 10.1097/01.ASN.0000024436.00520.D8 12138133 (Pubitemid 34790778)
13. Vascular endothelial growth factor/vascular permeability factor is temporarily and spatially correlated with ocular angiogenesis in a primate model. Miller JW, Adamis AP, Shima DT, Am J Pathol 1994 145 574 84 7521577 (Pubitemid 24285965)
14. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Aiello LP, Northrup JM, Keyt BA, Arch Ophthalmol 1995 113 1538 44 10.1001/archopht.1995.01100120068012 7487623
15. The reguation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium. Ikeda Y, Yonemitsu Y, Onimaru M, Exp Eye Res 2006 83 1031 1040 10.1016/j.exer.2006.05.007 16842779 (Pubitemid 44397024)
16. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Ribatti D, Br J Haematol 2005 128 303 309 10.1111/j.1365-2141.2004.05291.x 15667531 (Pubitemid 40216151)
17. Vascular endothelial growth factor and the regulation of angiogenesis. Ferrara N, Recent Prog Horm Res 2000 55 15 35 11036931
18. The biology of VEGF and its receptors. Ferrara N, Gerber HP, LeCouter J, Nat Med 2003 9 669 676 10.1038/nm0603-669 12778165 (Pubitemid 36749215)
19. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. Robinson CJ, Stringer SE, J Cell Sci 2001 114 853 865 11181169 (Pubitemid 32273121)
20. 2tension. Wang GL, Jiang BH, Rue EA, Semenza GL, Proc Natl Acad Sci USA 1995 92 5510 5514 10.1073/pnas.92.12.5510 7539918
21. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Yamamoto Y, Gaynor RB, Curr Mol Med 2001 1 287 296 10.2174/ 1566524013363816 11899077 (Pubitemid 33773312)
22. Introduction to NF-B: players, pathways, perspectives. Gilmore TD, Oncogene 2006 25 6680 6684 10.1038/sj.onc.1209954 17072321 (Pubitemid 44657845)
23. Mechanism of hypoxia induced NFkappaB. Culver C, Sundqvist A, Mudie S, Melvin A, Xirodimas D, Rocha S, Mol Cell Biol 2010 30 4901 4921 10.1128/MCB.00409-10 20696840
24. Vascular endothelial growth factors and angiogenesis in eye disease. Witmer AN, Vrensen GF, Prog Retin Eye Res 2003 22 1 29 10.1016/S1350-9462(02) 00043-5 12597922 (Pubitemid 36207453)
25. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Amin R, Puklin JE, Frank RN, Investig Ophthalmol Vis Sci 1994 35 3178 3188 (Pubitemid 24241356)
26. Hypoxia-inducible factor expression in human RPE cells. Forooghian F, Razavi R, Timms L, Br J Ophthalmol 2007 91 1406 1410 10.1136/bjo.2007.123125 17567660 (Pubitemid 47492884)
27. Active HIF-1 in the normal human retina. Hughes JM, Groot AJ, van der Groep P, Sersansie R, Vooijs M, van Diest PJ, Van Noorden CJ, Schlingemann RO, Klaassen I, J Histochem Cytochem 2010 58 247 54 10.1369/jhc.2009.953786 19901273
28. Hypoxia-inducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia. Håkansson G, Gesslein B, Gustafsson L, Englund-Johansson U, Malmsjö M, J Ocul Biol Dis Infor 2010 3 20 29 10.1007/s12177-010-9050-6 21139705
29. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Caldwell RB, Bartoli M, Behzadian MA, Curr Drug Targets 2005 6 511 524 10.2174/1389450054021981 16026270 (Pubitemid 40916276)
30. Establishment of a human retinal cell line by transfection of SV40 T antigen gene with potential to undergo neuronal differentiation. Dutt K, Scott M, Wang M, Semple B, Srinivasan A, DNA Cell Biol 1994 13 909 921 10.1089/dna.1994.13.909 7917013 (Pubitemid 24376823)
31. Generation of 3D retina-like structures from a human retinal cell line in a NASA bioreactor. Dutt K, Harris-Hooker S, Ellerson D, Layne D, Kumar R, Hunt R, Cell Transplant 2003 12 717 31 14653619 (Pubitemid 37409740)
32. Three-dimensional growth of retinal and endothelial cell co-cultures in the horizontally rotating bioreactor. Dutt K, Harris-Hooker S, Sanford G, Hunt R, Layne D, Ellerson D, Invest Ophthalmol Vis Sci 1999 40 614
33. The expression of growth factors and their receptors in retinal and endothelial cells co-cultured in the rotating bioreactor. Kumar R, Harris-Hooker S, Sanford GL, Ethnicity and Disease 2008 18 44 50
34. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Adamis AP, Shima DT, Tolentino MJ, Arch Ophthalnol 1996 114 66 71 10.1001/archopht.1996. 01100130062010 (Pubitemid 26026196)
35. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Duh E, Aiello LP, Diabetes 1999 48 1899 906 10.2337/diabetes.48.10.1899 10512352 (Pubitemid 29458350)
36. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intra-retinal and subretinal neovascularization. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA, Am J Pathol 1997 151 281 291 9212753
37. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases. Aiello LP, Avery RL, N Engl J Med 1994 331 1480 1487 10.1056/NEJM199412013312203 7526212 (Pubitemid 24356306)
38. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF, Arch Ophthalmol 1996 114 1210 7 10.1001/archopht.1996.01100140410008 8859080 (Pubitemid 26338852)
39. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX, J Mol Endocrinol 2006 37 1 12 10.1677/jme.1.02008 16901919 (Pubitemid 44288601)
40. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE, Proc Natl Acad Sci USA 1995 92 10457 10461 10.1073/pnas.92.23.10457 7479819
41. Enhancement of angiogenic potential of endothelial cells by contact with retinal pigment epithelial cells in a model simulating pathological conditions. Dardik R, Livnat T, Nisgav Y, Weinberger D, Invest Ophthalmol Vis Sci 2010 51 6188 95 10.1167/iovs.09-5095 20702828
42. Autocrine VEGF signaling is required for vascular homeostasis. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML, Cell 2007 130 691 703 10.1016/j.cell.2007.06.054 17719546 (Pubitemid 47268059)
43. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. Yang K, Cepko CL, J Neurosci 1996 16 6089 6099 8815891 (Pubitemid 26313984)
44. Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Ferrara N, Nat Med 2010 16 1107 10.1038/nm1010-1107 20930754
45. Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. Yoshida A, Yoshida S, Ishibashi T, Kuwano M, Inomata H, Invest Ophthalmol Vis Sci 1999 40 1624 9 10359349 (Pubitemid 29252358)
46. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor. Morais C, Gobe G, Johnson DW, Healy H, Angiogenesis 2009 12 365 79 10.1007/s10456-009-9158-0 19882112